Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
Immunome is seeking a Senior Director, Global Market Development to lead the company’s strategic engagement with Key Opinion Leaders (KOLs), scientific societies, and influential clinical stakeholders across the worldwide desmoid tumor community. This senior leader will shape the global scientific and clinical environment for varegacestat and future pipeline assets.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
Immunome, Inc.